In this episode, we challenge the outdated framing that commercial value-based care is just Medicare-with-a-delay. Using primary-source data from Cigna, Elevance, Blue Shield, and others, we examine how commercial VBC has crossed into genuine operational reality—but with a structural complexity that Medicare's playbook never had to solve. We explore why…
